On September 1, 2026, John D. Couling, senior vice president of entertainment at Dolby Laboratories, sold 7,667 shares of Class A common stock. The sale was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on September 3, 2026. The shares were sold at prices ranging from $60.65 to $61.25, with a weighted‑average price of $61.045 per share, generating proceeds of $468,032.
Earlier that day Couling exercised fully vested employee stock options to acquire the same 7,667 shares at $45.50 per share, costing $348,848. The options were part of an original grant for 46,000 Class A shares.
Following the sale and option exercise, Couling’s direct holdings amounted to 118,727 Class A shares, which include 55,114 shares underlying restricted stock units that remain subject to forfeiture.
Dolby Laboratories’ stock was trading around $61.92 at the time of the filing, close to the sale price. The company had just reported its fiscal third‑quarter 2026 results, posting non‑GAAP earnings per share of $0.69 versus the $0.67 consensus, while revenue of $305 million fell short of the $311.96 million forecast. Management indicated a strong outlook for the next quarter, driven by anticipated deals.
